These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4260957)

  • 1. Treatment of involuntary movement disorders with tetrabenazine.
    Swash M; Roberts AH; Zakko H; Heathfield KW
    J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):186-91. PubMed ID: 4260957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suppression of involuntary movements with tetrabenazine.
    McLellan DL
    Scott Med J; 1972 Nov; 17(11):367-70. PubMed ID: 4264428
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J
    Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrabenazine for involuntary movement disorders.
    Kingston D
    Med J Aust; 1979 Jun; 1(13):628-30. PubMed ID: 158700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J; Orman J
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrabenazine and movement disorders.
    Asher SW; Aminoff MJ
    Neurology; 1981 Aug; 31(8):1051-4. PubMed ID: 6455607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tetrabenazine on extrapyramidal movement disorders.
    Dalby MA
    Br Med J; 1969 May; 2(5654):422-3. PubMed ID: 4238453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS; Wodak J; Veale JL; Munro OR
    Med J Aust; 1972 Nov; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract]   [Full Text] [Related]  

  • 10. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrabenazine in the treatment of Huntington's chorea.
    Huang CY; McLeod JG; Holland RT; Elliot C
    Med J Aust; 1976 Apr; 1(16):583-4. PubMed ID: 132600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of tetrabenazine in hyperkinetic movement disorders.
    Jankovic J; Beach J
    Neurology; 1997 Feb; 48(2):358-62. PubMed ID: 9040721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrabenazine for Huntington's chorea.
    Soutar CA
    Br Med J; 1970 Oct; 4(5726):55. PubMed ID: 4248502
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha methylparatyrosine and tetrabenazine in movement disorders.
    Lang AE; Marsden CD
    Clin Neuropharmacol; 1982 Dec; 5(4):375-87. PubMed ID: 6130839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of diseases characterized by abnormal movements.
    Marsden CD
    Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
    [No Abstract]   [Full Text] [Related]  

  • 17. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutical approach to involuntary movements (author's transl)].
    Allain H; Sabouraud O
    Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of severe dystonia in children and adults.
    Marsden CD; Marion MH; Quinn N
    J Neurol Neurosurg Psychiatry; 1984 Nov; 47(11):1166-73. PubMed ID: 6502174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.